Deng Gary
Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Med Acupunct. 2020 Dec 1;32(6):394-395. doi: 10.1089/acu.2020.1494. Epub 2020 Dec 16.
High-symptom burdens, including pain, are associated with high-dose chemotherapy. We conducted a pilot study to evaluate how acupuncture may affect symptom burden and use of pain medication. This is a randomized sham acupuncture (SA) controlled trial. An academic cancer center. Patients were with multiple myeloma undergoing autologous hematopoietic stem cell transplantation. Once daily acupuncture for 5 days after high-dose chemotherapy. M. D. Anderson Symptom Inventory (MDASI), opioid use. Compared with SA, true acupuncture reduced nausea, poor appetite, and drowsiness, and use of opioids in opioid-naive patients. Yes. Investigators and study participants were blinded. Further study of acupuncture in a larger trial is warranted for its effect on reducing opioid use and symptom burdens during high-dose chemotherapy. Registration: NCT01811862.
包括疼痛在内的高症状负担与高剂量化疗相关。我们开展了一项试点研究,以评估针灸如何影响症状负担及止痛药物的使用。这是一项随机假针刺(SA)对照试验。研究地点为一家学术性癌症中心。患者为正在接受自体造血干细胞移植的多发性骨髓瘤患者。在高剂量化疗后每天进行一次针灸,共5天。采用MD安德森症状问卷(MDASI)及阿片类药物使用情况进行评估。与假针刺相比,真针刺可减轻恶心、食欲减退和嗜睡症状,并减少未使用过阿片类药物患者的阿片类药物使用量。研究人员和研究参与者均采用了盲法。鉴于针灸在减轻高剂量化疗期间阿片类药物使用及症状负担方面的作用,有必要在更大规模的试验中对其进行进一步研究。注册号:NCT01811862。